Zomig Nasal (Zolmitriptan): Uses, Side Effects and Dosage

Patient information: uses, side effects, how to take - Zomig Nasal

Instructions for Use

ZOMIG® (Zo-mig)

(zolmitriptan)

Nasal Spray

Important: For use in your nose only. Do not spray in your eyes.

Note: There is only 1 dose in the nasal sprayer. Do not try to prime the nasal sprayer or you will lose the dose. Do not press the plunger until you have put the tip into your nostril or you will lose the dose.

Steps for using ZOMIG Nasal Spray

Step 1. Remove the ZOMIG Nasal Spray unit from the single use package it comes in. Do not remove the unit until you are ready to use it. The unit contains only 1 spray.

Step 2. Blow your nose gently to clear your nasal passages before use.

Step 3. Remove the protective cap (See Figure A).

Step 4. Keeping your head in an upright position, gently close 1 nostril with your index finger and breathe out gently through your mouth. (See Figure B). Either nostril can be used.

Step 5. With your other hand, hold the container with your thumb supporting the container at the bottom, and your index and middle fingers on each side of the nozzle. (See Figure C).

Insert the tip of the sprayer device into your open nostril as far as feels comfortable and tilt your head slightly (See Figure D).

Do not press the plunger yet.

Step 6. Breathe in gently through your nose and at the same time press the plunger firmly with your thumb to release your dose of ZOMIG Nasal Spray (See Figure D).

The plunger may feel stiff and you may hear a click. Keep your head slightly tilted back and remove the tip from your nose. Breathe gently through your mouth for 5 to 10 seconds. You may feel liquid in your nose or the back of your throat. This is normal.

Step 7. Dispose the ZOMIG Nasal Spray device after completing the full dose or as soon as it becomes outdated or no longer needed. Dispose of properly. Keep out of reach of children. Do not reuse.

This Patient Information and Instructions for Use have been approved by the U.S. Food and Drug Administration.

ZOMIG is a registered trademark of the AstraZeneca group of companies.

Other brands mentioned are trademarks of their respective owners and are not trademarks of the AstraZeneca group of companies. The makers of these brands are not affiliated with AstraZeneca or its products.

Revised 04/2019

Distributed by:

Amneal Specialty, a division of Amneal Pharmaceuticals LLC

Bridgewater, NJ 08807

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 021450 · View the label on DailyMed

Revision date stated in the text: April 2019

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Zomig Nasal

Rx or OTC

Prescription (Rx)?

This drug is available only with a prescription from a licensed healthcare provider.
Rx

Drug class

Serotonin-1b and Serotonin-1d Receptor Agonist

Active ingredient

Zolmitriptan

Dosage form

Spray, metered

Route

Nasal

Marketing status

not in the current FDA NDC Directory

Company (applicant)

AMNEAL

FDA approval

NDA 021450New Drug Application (NDA) Approved September 30, 2003

Reference listed drug

This is the reference listed drug (RLD) that generics are compared with.

Therapeutic equivalence (TE) code

ABCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).

Manufacturers

1 labelers list this drug on DailyMed

Packages (NDC)

Package
2.5 mg – 1 in 1 bottle, spray / 6 in 1 carton NDC 64896-083-12
5 mg – 1 in 1 bottle, spray / 6 in 1 carton NDC 64896-084-12

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.